Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma
Clinical trial NCT04937387 · COMPLETED
Trial details
- NCT number
- NCT04937387
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-29
- Primary completion
- 2024-08-05
- Enrollment
- 359
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.